Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Latvia

Latvia: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and was 13.3% in 2021. ▼ Falling

Latest (2021)
13.3%
Change on year
up 3.1%
World rank
112th
of 185 countries
All-time high
18.8%
in 2001
All-time low
12.9%
in 2020
Years of data
22
2000–2021

Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Latvia, 2000–2021

051015202000201020212000: 17.9 %2001: 18.8 %2002: 18.4 %2003: 18.5 %2004: 17.9 %2005: 17.3 %2006: 18.5 %2007: 17.7 %2008: 16.8 %2009: 16.4 %2010: 16.6 %2011: 16 %2012: 15 %2013: 14.5 %2014: 14.3 %2015: 13.9 %2016: 13.6 %2017: 13.8 %2018: 14.1 %2019: 13 %2020: 12.9 %2021: 13.3 %

Source: World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO). Measured in %.

Analysis

In 2021, mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Latvia stood at 13.3%.

Compared with earlier readings it is up 3.1% on the previous year and down 16.9% over ten years.

Over the whole period, mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Latvia peaked at 18.8% in 2001 and was at its lowest, 12.9%, in 2020.

Latvia ranks 112th of 185 countries on this measure, in the middle of the range.

The long-run direction has been consistently falling across the 22 years of available data.

Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Latvia, year by year

Annual values for Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%) in Latvia, 2000 to 2021.
Year % Change
2000 17.9%
2001 18.8% +5.0%
2002 18.4% -2.1%
2003 18.5% +0.5%
2004 17.9% -3.2%
2005 17.3% -3.4%
2006 18.5% +6.9%
2007 17.7% -4.3%
2008 16.8% -5.1%
2009 16.4% -2.4%
2010 16.6% +1.2%
2011 16.0% -3.6%
2012 15.0% -6.2%
2013 14.5% -3.3%
2014 14.3% -1.4%
2015 13.9% -2.8%
2016 13.6% -2.2%
2017 13.8% +1.5%
2018 14.1% +2.2%
2019 13.0% -7.8%
2020 12.9% -0.8%
2021 13.3% +3.1%

Latvia compared with similar countries

  • Latvia's 13.3% is above the median for high income countries, which is 8.7%, 1.5× the median. (58 countries reporting)
  • Latvia's 13.3% is above the median for Europe & Central Asia, which is 10.4%, 1.3× the median. (48 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2000s 17.8% 16.4% 18.8% 10
2010s 14.5% 13.0% 16.6% 10
2020s 13.1% 12.9% 13.3% 2

Countries ranked near Latvia

  1. 109 Mexico 13.8% compare
  2. 109 Paraguay 13.8% compare
  3. 111 Montenegro 13.4% compare
  4. 112 Oman 13.3% compare
  5. 112 Saudi Arabia 13.3% compare
  6. 112 Seychelles 13.3% compare

See the full ranking of 232 places →

More health data for Latvia

All data for Latvia →

Frequently asked questions

What is mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Latvia?
Mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Latvia was 13.3% in 2021, according to World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO).
What is the highest mortality from cvd, cancer, diabetes or crd between exact ages 30 and recorded in Latvia?
The highest recorded value was 18.8% in 2001.
What is the lowest mortality from cvd, cancer, diabetes or crd between exact ages 30 and recorded in Latvia?
The lowest recorded value was 12.9% in 2020.
How does Latvia rank for mortality from cvd, cancer, diabetes or crd between exact ages 30 and?
Latvia ranks 112th out of 185 countries with data for 2021.
Is mortality from cvd, cancer, diabetes or crd between exact ages 30 and rising or falling in Latvia?
Over the last ten years it is down 16.9%. The long-run trend across the full record is falling.
Where does this Latvia data come from?
The figures come from World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO), published as part of Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 22 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Latvia. Statizoid, drawing on World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO). Retrieved 14 September 2026, from https://health.statizoid.com/stat/mortality-from-cvd-cancer-diabetes-or-crd-between-exact-ages-30-and-70-female-percent/latvia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/mortality-from-cvd-cancer-diabetes-or-crd-between-exact-ages-30-and-70-female-percent/latvia/">Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Latvia</a> — Statizoid

About this data

Indicator
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%)
Unit
%
Source
World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
232 places, 5,104 data points, 2000–2021
Last refreshed

Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).